Radboudumc and partners Help Cell4Pharma

21 December 2022

We need to work towards a future where organ on a chip technology is more accurate in mimicking the human body than any animal could ever be.Because over 110 million animals are used in experiments to develop new medicine. Organ by organ we will need to develop better alternatives than the experiments that are done on animals now.

Our spin-off company Cell4Pharma focuses on developing a model that is more accurate in mimicking the human kidney than any other animal experiment on the market.

Grab this opportunity to be part of their mission and become an investor.

Check out their crowdfunding page on Symbid here: http://www.symbid.nl/projects/427

Related news items

Third Radboudumc Investment Day again well-attended

16 October 2023

On October 12, the Radboudumc Investment Day took place for the third time. Scientists, entrepreneurs and investors from the life sciences & health sector came together in the Radboudumc Experience Center to exchange knowledge, network and talk about new collaborations.

read more

Soteria Medical BV announces collaboration with ALLEAD

27 July 2023

Radboudumc spin-off Soteria Medical BV announces collaboration with ALLEAD.

read more

Take Off 2 funding from NWO for Predica Diagnostics

30 June 2023

Predica Diagnostics just secured the Take Off 2 funding to accelerate development of their cervical (pre)cancer prediction test.

read more

Boosting the startup ecosystem in Nijmegen!

22 June 2023

TechleapNL, Radboud university, Radboudumc and the municipality of Nijmegen hosted a successful event where innovative health and hightech startups shared their view on the challenges and opportunities for the local startup ecosystem.

read more

Meet Healthy Ideas, Healthy Returns

2 June 2023

Do you have a golden idea to improve healthcare, but not the resources to realize it? Discover Healthy Ideas, Healthy Returns: a Benelux-wide public-private network offering opportunities for healthcare investments and propositions, among other things.

read more